Continuum Advisory, LLC

SEC CIK: 0001846532
Latest filing: Aug 6, 2026

SEC filings (opens in a new tab)

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Continuum Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overview All 13F holders of APLS Full Q2 2026 holdings

Shares (Q3 2024): 0; Sold out in Q3 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2024

Holdings of APLS by Continuum Advisory, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2024	0	$0	0.0%	−37−100.0%	Sold out	Holders
Q2 2024	37	$1.42K	<0.1%	+8+27.6%	Added	Holders
Q1 2024	29	$1.23K	<0.1%	+29	New	Holders